Health & Medicine
A pair of Rutgers professors have partnered with a former colleague to form a startup with the goal of developing novel cancer treatments based on the use of antibody drug conjugates.
Stories
Rutgers researcher discovers possible link of mitochondrial function to the development of schizophrenia.
Rutgers researchers nearly swept the 2023 Philadelphia Nucleate Activator Program awards, highlighted by a team focusing on the creation of a new binge-eating disorder drug taking the High Performance Grand Prize.
Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.
Rutgers study finds that people informed of high genetic risk would plan to modify their behavior.
A five-year federal grant awarded to Rutgers University-Newark will soon begin examining whether something as simple as rigorous exercise can help stave off Alzheimer's disease in African Americans.